Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 3066 (LINC03066) is a human gene that encodes a long intergenic non-coding RNA (lincRNA), which refers to autonomously transcribed RNA longer than 200 nucleotides that do not overlap any protein-coding gene[9][1][7]. The canonical symbol is LINC03066, and it is cataloged in databases such as NCBI Gene and Ensembl[7]. Like other lincRNAs, it may participate in genome organization, chromatin remodeling, RNA stabilization, or gene expression regulation, but no specific biological or disease role has been documented for LINC03066. There are currently no drugs targeting this RNA, nor is it identified as a biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 3066 (LINC03066).